Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 1
Submit an article Journal homepage
8
Views
0
CrossRef citations to date
0
Altmetric
Articles

Fulminant myocarditis with dramatic response to corticoids

Mickaël MoreelsDepartment of Cardiology, Belgium.
, MD,
Marie-Luce DelforgeVirology, Erasme University Hospital, Brussels, Belgium.
, MD, PhD &
Marc RenardDepartment of Cardiology, Belgium.Correspondence[email protected]
, MD, PhD
Pages 97-99 | Received 08 Aug 2009, Accepted 04 Nov 2009, Published online: 23 May 2017

References

  • McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) myocarditis. N Engl J Med 2000; 342: 690–5.
  • Cooper LT. Myocarditis. N Engl J Med 2009; 360: 1526–38.
  • Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute fulminant myocarditis in children. Heart 2006; 92: 1269–73.
  • Chen Y-S, Yu H-Y, Huang S-C, Chiu K-M, Lin T-Y, Lai L-P, Lin F-Y, Wang S-S, Chu S-H, Ko W-J. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first? J Heart Lung Transpl 2005; 24: 81–7.
  • Nishii M, Inomata T, Takehana H, Takeuchi I, Nakano H, Koitabashi T, Nakahata J-I, Aoyama N, Izumi T. Serum levels of interleukin-10 on admission as a prognostic pre-dictor of human fulminant myocarditis. J Am Coll Cardiol 2004; 44: 1292–7.
  • Wu XM, Chen JJ, Wu CK, Lin LY, Tseng CD. Pheochro-mocytoma presenting as acute myocarditis with cardiogenic shock in two cases. Intern Med 2008; 47: 2151–5.
  • Yukiiri K, Mizushige K, Ueda T, Nanba T, Tanimoto K, Wada Y, Takagi Y, Ohmori K, Kohno M. Fulminant myocarditis in polymyositis. Jpn Circ J2001; 65: 991–3.
  • Kato S, Morimoto S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, Miyagishima K, Yoshida Y, Hashimoto S, Hishida H. Risk factors for patients developing a fulminant course with acute myocarditis. Circ J2004; 68: 734–9.
  • Kato S, Morimoto S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, Miyagishima K, Mori N, Hishida H. Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis. Heart Vessels 2007; 22: 48–51.
  • Watanabe N, Nakagawa S, Fukunaga T, Fukuoka S, Hatakeyama K, Hayashi T. Acute necrotizing eosinophilic myocarditis successfully treated by high dose methylpred-nisolone. Jpn Circ J2001; 65: 923–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.